We have located links that may give you full text access.
EVALUATION STUDY
JOURNAL ARTICLE
Robotic resection of benign nonadrenal retroperitoneal tumors: A consecutive case series.
International Journal of Surgery 2018 July
BACKGROUND: The deep location, narrow operative space and proximity to major vessels make minimally invasive resection of nonadrenal retroperitoneal tumors (NTRs) challenging and rarely reported. This study aimed to evaluate the safety and feasibility of robotic resection of benign nonadrenal retroperitoneal tumors.
METHODS: The demographics and perioperative outcomes of a consecutive series of patients who underwent robotic NTR resection between January 1, 2015, and August 30, 2017, were analyzed.
RESULTS: Twenty-five patients (9 men and 16 women; mean age, 50.5 years) were included in the study. The mean largest tumor diameter was 4.9 cm, 11 had a tumor larger than 5 cm and 13 had a tumor adherent to major vessels. The mean operative time was 139.0 min, and the median estimated blood loss was 50.0 mL (interquartile range, 30-80 mL). No patients required conversion to laparotomy or blood transfusion. Postoperative morbidities occurred in 3 patients (12%), and all recovered after conservative treatment. The mean postoperative hospital stay was 4.8 days. On histopathological examination all the tumors were benign: lymphangioma (8, 32%), schwannoma (5, 20%), lymphatic cyst (4, 16%), paraganglioma (2, 8%), bronchogenic cyst (2, 8%), mucinous cystadenoma (1, 4%), neurofibroma (1, 4%), ganglioneuroma (1, 4%), and Castleman disease (1, 4%). Neither large tumor size nor adherence to major vessels affected the perioperative outcomes.
CONCLUSIONS: Robotic resection of NRTs is safe and feasible even for tumors which were large or adherent to major vessels.
METHODS: The demographics and perioperative outcomes of a consecutive series of patients who underwent robotic NTR resection between January 1, 2015, and August 30, 2017, were analyzed.
RESULTS: Twenty-five patients (9 men and 16 women; mean age, 50.5 years) were included in the study. The mean largest tumor diameter was 4.9 cm, 11 had a tumor larger than 5 cm and 13 had a tumor adherent to major vessels. The mean operative time was 139.0 min, and the median estimated blood loss was 50.0 mL (interquartile range, 30-80 mL). No patients required conversion to laparotomy or blood transfusion. Postoperative morbidities occurred in 3 patients (12%), and all recovered after conservative treatment. The mean postoperative hospital stay was 4.8 days. On histopathological examination all the tumors were benign: lymphangioma (8, 32%), schwannoma (5, 20%), lymphatic cyst (4, 16%), paraganglioma (2, 8%), bronchogenic cyst (2, 8%), mucinous cystadenoma (1, 4%), neurofibroma (1, 4%), ganglioneuroma (1, 4%), and Castleman disease (1, 4%). Neither large tumor size nor adherence to major vessels affected the perioperative outcomes.
CONCLUSIONS: Robotic resection of NRTs is safe and feasible even for tumors which were large or adherent to major vessels.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app